Teva Pharmaceutical Industries Limited Introduces First Generic Lamictal(R) Tablets in the United States

July 22, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has commenced commercial shipment of its generic version of Lamictal® (Lamotrigine) Tablets, 25mg, 100 mg, 150 mg, and 200 mg.

Twitter
LinkedIn
Facebook
Email
Print

Asia